Positron emission tomography (PET) uses radioactive tracers and enables the functional
imaging of several metabolic processes, blood flow measurements, regional chemical …

Rapid imaging acquisition, high spatial resolution and sensitivity, powered by
advancements in solid-state detector technology, are significantly changing the perspective …

Myocardial infarction (MI) is one of the leading causes of death worldwide, and inflammation
is central to tissue response and patient outcomes. The 18-kDa translocator protein (TSPO) …

Nowadays, emerging radiolabeled nanosystems are revolutionizing medicine in terms of
diagnostics, treatment, and theranostics. These radionuclides include polymeric …

Magnetic resonance imaging (MRI)/nuclear medicine imaging (NMI) dual-modality imaging
based on radiolabeled nanoparticles has been increasingly exploited for accurate diagnosis …

Targets play an indispensable and pivotal role in the development of radiopharmaceuticals.
However, the initial stages of drug discovery projects are often plagued by frequent failures …

Multimodal imaging (MMI) has emerged as a powerful tool in clinical research, combining
different imaging modes to acquire comprehensive information and enabling scientists and …

Breast cancer survival is significantly improved over the past decades due to major
improvements in anti-tumor therapies and the implementation of regular screening, which …

The development of new radiotracers for PET and SPECT is central to addressing unmet
diagnostic needs related to systemwide trends toward molecular characterization and …

Summary 13N-ammonia positron emission tomography (NH3-PET) can evaluate myocardial
blood flow (MBF) at rest, stress, and myocardial flow reserve (MFR) as well as the ratio of …